StockData
Pro Dex Inc logo

Pro Dex Inc (PDEX) stock

PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/3012% below fair value
$61.93−2.55 (-3.95%)

Close on Nov 17, 2026Market cap $198.18MP/E 17.1Yield –

Pro Dex operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Pro Dex's operating income for the twelve months ending Sep 30, 2026 was $13.40M, up 24.2% year over year. For fiscal 2026 it was $12.99M, up 21.5% from the year before. Over ten years it grew 32.0% a year on average. The highest annual figure on record is $12.99M in fiscal 2026.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026$12.99M+21.5%
FY2025Jun 30, 2025$10.69M+49.0%
FY2024Jun 30, 2024$7.17M+24.5%
FY2023Jun 30, 2023$5.76M+12.5%
FY2022Jun 30, 2022$5.12M+13.2%
FY2021Jun 30, 2021$4.53M-36.0%
FY2020Jun 30, 2020$7.07M+41.4%
FY2019Jun 30, 2019$5.00M+108.9%
FY2018Jun 30, 2018$2.39M-12.6%
FY2017Jun 30, 2017$2.74M+239.2%
FY2016Jun 30, 2016$807.00K–
FY2015Jun 30, 2015-$902.00K–
FY2014Jun 30, 2014-$814.00K–
FY2013Jun 30, 2013-$1.90M–
FY2012Jun 30, 2012-$1.37M-139.2%
FY2011Jun 30, 2011$3.48M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$3.52M+13.1%
Q4 FY2026CQ2 2026Jun 30, 2026$3.53M+162.6%
Q3 FY2026CQ1 2026Mar 31, 2026$3.09M-15.0%
Q2 FY2026CQ4 2025Dec 31, 2025$3.26M+21.1%
Q1 FY2026CQ3 2025Sep 30, 2025$3.11M+3.2%
Q4 FY2025CQ2 2025Jun 30, 2025$1.34M-42.8%
Q3 FY2025CQ1 2025Mar 31, 2025$3.64M+64.5%
Q2 FY2025CQ4 2024Dec 31, 2024$2.69M+246.5%
Q1 FY2025CQ3 2024Sep 30, 2024$3.01M+64.4%
Q4 FY2024CQ2 2024Jun 30, 2024$2.35M+46.0%
Q3 FY2024CQ1 2024Mar 31, 2024$2.21M+7.2%
Q2 FY2024CQ4 2023Dec 31, 2023$777.00K-31.7%
Q1 FY2024CQ3 2023Sep 30, 2023$1.83M+92.9%
Q4 FY2023CQ2 2023Jun 30, 2023$1.61M+36.1%
Q3 FY2023CQ1 2023Mar 31, 2023$2.07M+102.3%
Q2 FY2023CQ4 2022Dec 31, 2022$1.14M-29.0%
Q1 FY2023CQ3 2022Sep 30, 2022$950.00K-27.9%
Q4 FY2022CQ2 2022Jun 30, 2022$1.18M+100.5%
Q3 FY2022CQ1 2022Mar 31, 2022$1.02M-45.3%
Q2 FY2022CQ4 2021Dec 31, 2021$1.60M+207.5%
Q1 FY2022CQ3 2021Sep 30, 2021$1.32M-14.9%
Q4 FY2021CQ2 2021Jun 30, 2021$590.00K-73.2%
Q3 FY2021CQ1 2021Mar 31, 2021$1.87M+9.4%
Q2 FY2021CQ4 2020Dec 31, 2020$521.00K-68.8%
Q1 FY2021CQ3 2020Sep 30, 2020$1.55M+3.9%
Q4 FY2020CQ2 2020Jun 30, 2020$2.20M+86.6%
Q3 FY2020CQ1 2020Mar 31, 2020$1.70M+90.0%
Q2 FY2020CQ4 2019Dec 31, 2019$1.67M+39.8%
Q1 FY2020CQ3 2019Sep 30, 2019$1.49M-13.7%
Q4 FY2019CQ2 2019Jun 30, 2019$1.18M+120.6%
Q3 FY2019CQ1 2019Mar 31, 2019$897.00K+41.9%
Q2 FY2019CQ4 2018Dec 31, 2018$1.19M+240.9%
Q1 FY2019CQ3 2018Sep 30, 2018$1.73M+97.7%
Q4 FY2018CQ2 2018Jun 30, 2018$535.00K-35.2%
Q3 FY2018CQ1 2018Mar 31, 2018$632.00K-53.1%
Q2 FY2018CQ4 2017Dec 31, 2017$350.00K+30.1%
Q1 FY2018CQ3 2017Sep 30, 2017$874.00K–
Q4 FY2017CQ2 2017Jun 30, 2017$826.00K–
Q3 FY2017CQ1 2017Mar 31, 2017$1.35M–
Q2 FY2017CQ4 2016Dec 31, 2016$269.00K–

More Pro Dex figures

See a number that looks wrong?